IL197452A - Annotations 3– [h1– pyrrolo [3,2– b] pyridin-3-ram)] methylidene] -imidazolidin-2-on and pharmaceutical preparations containing them as anti-proliferative substances - Google Patents

Annotations 3– [h1– pyrrolo [3,2– b] pyridin-3-ram)] methylidene] -imidazolidin-2-on and pharmaceutical preparations containing them as anti-proliferative substances

Info

Publication number: IL197452A
Authority: IL; Israel
Prior art keywords: imidazolidin; methylidene; pyrrolo; pyridin; derivatives
Prior art date: 2006-10-12

Application number

IL197452A

Other languages

English (en)

Hebrew (he)

Other versions

IL197452A0 (en

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-12

Filing date

2009-03-05

Publication date

2015-10-29

2009-03-05 Application filed by Sanofi Sa filed Critical Sanofi Sa

2009-12-24 Publication of IL197452A0 publication Critical patent/IL197452A0/en

2015-10-29 Publication of IL197452A publication Critical patent/IL197452A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

IL197452A 2006-10-12 2009-03-05 Annotations 3– [h1– pyrrolo [3,2– b] pyridin-3-ram)] methylidene] -imidazolidin-2-on and pharmaceutical preparations containing them as anti-proliferative substances IL197452A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0608924A FR2907120B1 (fr)	2006-10-12	2006-10-12	Nouveaux derives imidazolones,leur preparation a titre de medicaments,compositions pharmaceutiques,utilisation comme inhibiteurs de proteines kinases notamment cdc7
PCT/FR2007/001651 WO2008046982A2 (fr)	2006-10-12	2007-10-10	Nouveaux derives imidazolones, leur preparation a titre de medicaments, compositions pharmaceutiques, utilisation comme inhibiteurs de proteines kinases notamment cdc7

Publications (2)

Publication Number	Publication Date
IL197452A0 IL197452A0 (en)	2009-12-24
IL197452A true IL197452A (en)	2015-10-29

Family

ID=37964098

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL197452A IL197452A (en)	2006-10-12	2009-03-05	Annotations 3– [h1– pyrrolo [3,2– b] pyridin-3-ram)] methylidene] -imidazolidin-2-on and pharmaceutical preparations containing them as anti-proliferative substances

Country Status (29)

Country	Link
US (1)	US8314121B2 (el)
EP (1)	EP2094699B1 (el)
JP (1)	JP2010505922A (el)
KR (1)	KR101552361B1 (el)
CN (1)	CN101522678A (el)
AR (1)	AR063249A1 (el)
AT (1)	ATE517105T1 (el)
AU (1)	AU2007311833B2 (el)
BR (1)	BRPI0719790A2 (el)
CA (1)	CA2660166C (el)
CL (1)	CL2007002934A1 (el)
CO (1)	CO6160310A2 (el)
CY (1)	CY1112066T1 (el)
DK (1)	DK2094699T3 (el)
EA (1)	EA018496B1 (el)
ES (1)	ES2370049T3 (el)
FR (1)	FR2907120B1 (el)
HR (1)	HRP20110759T1 (el)
IL (1)	IL197452A (el)
MA (1)	MA30877B1 (el)
MX (1)	MX2009003283A (el)
NO (1)	NO20091486L (el)
PL (1)	PL2094699T3 (el)
PT (1)	PT2094699E (el)
RS (1)	RS51985B (el)
SI (1)	SI2094699T1 (el)
TW (1)	TW200821310A (el)
UY (1)	UY30642A1 (el)
WO (1)	WO2008046982A2 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2423204A4 (en)	2009-04-20	2013-01-09	Sbi Biotech Co Ltd	THIAZOLIDINONDERIVAT
CA2767089A1 (en) *	2009-07-15	2011-01-20	Abbott Laboratories	Pyrrolopyridine inhibitors of kinases
KR101851130B1 (ko) *	2009-12-04	2018-04-23	센화 바이오사이언시즈 인코포레이티드	Ｃｋ2 억제제로서 피라졸로피리미딘 및 관련된 헤테로사이클
JP2013525354A (ja) *	2010-04-19	2013-06-20	アッヴィ・インコーポレイテッド	ピロロピリジン系キナーゼ阻害薬
USRE46815E1 (en) *	2011-03-31	2018-05-01	Carna Biosciences, Inc.	Furanone derivative
JP6569908B2 (ja)	2014-01-31	2019-09-04	カルナバイオサイエンス株式会社	抗がん剤組成物
GB201807147D0 (en)	2018-05-01	2018-06-13	Oncologica Uk Ltd	Therapeutic combination
KR102491260B1 (ko) *	2019-12-26	2023-01-27	연세대학교 산학협력단	피롤리딘 유도체 및 이를 포함하는 베타-아밀로이드 또는 타우 단백질 관련 질병의 예방 또는 치료용 약학 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6335342B1 (en)	2000-06-19	2002-01-01	Pharmacia & Upjohn S.P.A.	Azaindole derivatives, process for their preparation, and their use as antitumor agents
EP2295433A3 (en)	2003-03-06	2011-07-06	Eisai R&D Management Co., Ltd.	JNK inhibitors
WO2005014572A1 (en) *	2003-08-08	2005-02-17	Pharmacia Italia S.P.A.	Pyrimidylpyrrole derivatives active as kinase inhibitors
WO2005103050A2 (en)	2004-04-02	2005-11-03	Vertex Pharmaceuticals Incorporated	Azaindoles useful as inhibitors of rock and other protein kinases
RU2391342C2 (ru) *	2004-10-14	2010-06-10	Ф.Хоффманн-Ля Рош Аг	Новые азаиндолтиазолиноны в качестве противораковых агентов
US7371862B2 (en) *	2005-11-11	2008-05-13	Pfizer Italia S.R.L.	Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them

2006
- 2006-10-12 FR FR0608924A patent/FR2907120B1/fr not_active Expired - Fee Related
2007
- 2007-10-10 BR BRPI0719790-0A2A patent/BRPI0719790A2/pt not_active IP Right Cessation
- 2007-10-10 MX MX2009003283A patent/MX2009003283A/es active IP Right Grant
- 2007-10-10 DK DK07858418.2T patent/DK2094699T3/da active
- 2007-10-10 KR KR1020097007392A patent/KR101552361B1/ko not_active Expired - Fee Related
- 2007-10-10 SI SI200730750T patent/SI2094699T1/sl unknown
- 2007-10-10 CA CA2660166A patent/CA2660166C/fr not_active Expired - Fee Related
- 2007-10-10 AT AT07858418T patent/ATE517105T1/de active
- 2007-10-10 JP JP2009531874A patent/JP2010505922A/ja not_active Revoked
- 2007-10-10 PT PT07858418T patent/PT2094699E/pt unknown
- 2007-10-10 ES ES07858418T patent/ES2370049T3/es active Active
- 2007-10-10 EA EA200970364A patent/EA018496B1/ru not_active IP Right Cessation
- 2007-10-10 PL PL07858418T patent/PL2094699T3/pl unknown
- 2007-10-10 WO PCT/FR2007/001651 patent/WO2008046982A2/fr active Application Filing
- 2007-10-10 CN CNA2007800378600A patent/CN101522678A/zh active Pending
- 2007-10-10 RS RS20110456A patent/RS51985B/en unknown
- 2007-10-10 AU AU2007311833A patent/AU2007311833B2/en not_active Ceased
- 2007-10-10 EP EP07858418A patent/EP2094699B1/fr active Active
- 2007-10-11 AR ARP070104500A patent/AR063249A1/es unknown
- 2007-10-11 CL CL200702934A patent/CL2007002934A1/es unknown
- 2007-10-12 UY UY30642A patent/UY30642A1/es not_active Application Discontinuation
- 2007-10-12 TW TW096138357A patent/TW200821310A/zh unknown
2009
- 2009-03-05 IL IL197452A patent/IL197452A/en not_active IP Right Cessation
- 2009-03-31 US US12/415,391 patent/US8314121B2/en not_active Expired - Fee Related
- 2009-04-08 CO CO09036259A patent/CO6160310A2/es unknown
- 2009-04-16 NO NO20091486A patent/NO20091486L/no not_active Application Discontinuation
- 2009-05-08 MA MA31856A patent/MA30877B1/fr unknown
2011
- 2011-10-19 HR HR20110759T patent/HRP20110759T1/hr unknown
- 2011-10-20 CY CY20111100996T patent/CY1112066T1/el unknown

Also Published As

Publication number	Publication date
FR2907120A1 (fr)	2008-04-18
NO20091486L (no)	2009-04-16
PL2094699T3 (pl)	2011-12-30
KR20090064571A (ko)	2009-06-19
AU2007311833B2 (en)	2013-05-02
CL2007002934A1 (es)	2008-05-30
CA2660166A1 (fr)	2008-04-24
WO2008046982A2 (fr)	2008-04-24
MA30877B1 (fr)	2009-11-02
FR2907120B1 (fr)	2013-01-11
CA2660166C (fr)	2015-12-29
KR101552361B1 (ko)	2015-09-10
IL197452A0 (en)	2009-12-24
ES2370049T3 (es)	2011-12-12
EA200970364A1 (ru)	2009-10-30
US20090253679A1 (en)	2009-10-08
DK2094699T3 (da)	2011-11-07
CN101522678A (zh)	2009-09-02
JP2010505922A (ja)	2010-02-25
EA018496B1 (ru)	2013-08-30
EP2094699B1 (fr)	2011-07-20
SI2094699T1 (sl)	2011-11-30
TW200821310A (en)	2008-05-16
ATE517105T1 (de)	2011-08-15
WO2008046982A3 (fr)	2008-06-19
MX2009003283A (es)	2009-04-08
US8314121B2 (en)	2012-11-20
AR063249A1 (es)	2009-01-14
HRP20110759T1 (hr)	2011-11-30
CO6160310A2 (es)	2010-05-20
EP2094699A2 (fr)	2009-09-02
PT2094699E (pt)	2011-10-24
AU2007311833A1 (en)	2008-04-24
BRPI0719790A2 (pt)	2014-11-25
RS51985B (en)	2012-02-29
UY30642A1 (es)	2008-05-31
CY1112066T1 (el)	2015-11-04

Publication	Publication Date	Title
HK1138589A1 (en)	2010-08-27	Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
IL197452A (en)	2015-10-29	Annotations 3– [h1– pyrrolo [3,2– b] pyridin-3-ram)] methylidene] -imidazolidin-2-on and pharmaceutical preparations containing them as anti-proliferative substances
IL198509A0 (en)	2010-02-17	Azaindole derivatives, compositions containing the same and uses thereof
HK1135976A1 (en)	2010-06-18	Pyridin-3-yl derivatives as immunomodulating agents
IL191902A0 (en)	2008-12-29	Azaindole derivatives and pharmaceutical compositions containing the same
HK1128471A1 (en)	2009-10-30	Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents
IL193141A (en)	2017-10-31	Compounds including pyrrolo [2,3– d] pyrimidine 7 - yl and sulphamate, pharmaceuticals and their use
IL197393A0 (en)	2009-12-24	Pyridin-4-yl derivatives as immunomodulating agents
ZA201100429B (en)	2012-03-28	Novel imidazo [1,2-a]pyrimidine derivatives,method for the preparation thereof,use thereof as medicaments,pharmaceutical compositions and novel use in particular as met inhibitors
IL194010A (en)	2015-10-29	Pyrzolido [4,3– d] derivatives, pyrimidine containing preparations and their use
AP2453A (en)	2012-08-31	Pyrazolo(3,4-B) pyridine derivatives as phosphodiesterase inhibitors
IL210688A0 (en)	2011-03-31	Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
IL196653A (en)	2015-04-30	Kempthetine derivatives, preparations containing them, their uses for drug preparation and processes for their preparation
IL205189A (en)	2014-09-30	7,6-dihydro-h5-imidazo [2,1- α] imidazole-3-carboxamide and their pharmaceutical preparations
IL185870A (en)	2013-06-27	H8-pyrido [3,2 – d] pyramidine-7-ben histones preserved in positions 2, 4, 8 that act as csbp / rk / p38 kinase inhibitors and their pharmaceuticals containing them
ZA201005959B (en)	2011-04-28	4-(pyrrolo[2,3-c]pyridine-3-yl)-pyrimidine-2-amine derivatives
ZA201100428B (en)	2012-03-28	Imidazo [1,2-a]pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
HK1142323A1 (en)	2010-12-03	6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
HK1104823A1 (en)	2008-01-25	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof i
ZA200805566B (en)	2009-04-29	6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors
IL213589A (en)	2016-02-29	Annotations [d – 4 ′, 3 ′; d – 2,3] Pyrolysis, preparation and pharmaceutical preparations containing them
IL192988A (en)	2014-07-31	History of Amoebic Hepatitis, Methods of Preparation, Pharmaceutical Preparations Containing and Uses
IL188773A0 (en)	2008-08-07	Benzimidazoles and imidazopyridine derivatives and pharmaceutical compositions containing the same
IL176993A0 (en)	2006-12-10	Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
HUP0600920A3 (en)	2007-11-28	Substituted thieno[2,3-b]pyridines, process for their preparation, their use and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2016-02-29	FF	Patent granted
2016-11-30	MM9K	Patent not in force due to non-payment of renewal fees